Catalyst Wire Dossier Catalyst Wire Dossier

Nemonoxacin Malate

nemonoxacin · TaiGen Biotechnology Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nemonoxacin Malate, covering 2018-01-24 to 2018-01-24. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Clinical Study to Assess the Efficacy and Safety of Nemonoxacin Malate in Treating Adult Patients With Community-acquired Pneumonia (CAP) [Phase 2]

See pricing